Evogene Ltd.

Biotechnology • Healthcare • Rehovot, Israel • EVGN (NCM)

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses. The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.

Wikipedia

Stock Performance (90 Days)

Data through Dec 23, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

AI drug discovery firm Evogene brings in new dealmaker to lead partnerships - Stock Titan

Stock Titan • Dec 30

Evogene Appoints Dr. Olga Nissan as Vice President of Business Development to Drive AI-Driven Growth - The Globe and Mail

The Globe and Mail • Dec 31

Evogene Reports Third Quarter 2025 Financial Results - PR Newswire

PR Newswire • Nov 20

Panic Selling: Will Evogene Ltd stock remain a Wall Street favorite - 2025 Price Targets & Low Drawdown Trading Strategies - moha.gov.vn

moha.gov.vn • Jan 2

Evogene Ltd (EVGN) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ... - Yahoo Finance

Yahoo Finance • Aug 20

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Evogene Ltd. had layoffs?

No layoff events have been recorded for Evogene Ltd. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Evogene Ltd. have?

Evogene Ltd. has approximately 117 employees.

What industry is Evogene Ltd. in?

Evogene Ltd. operates in the Biotechnology industry, within the Healthcare sector.

Is Evogene Ltd. a publicly traded company?

Yes, Evogene Ltd. is publicly traded under the ticker symbol EVGN on the NCM. The company has a market capitalization of approximately $0.01 billion.

Where is Evogene Ltd. headquartered?

Evogene Ltd. is headquartered in Rehovot, Israel.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.